Vardhman Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 3.10 Cr
- Paid Up Capital ₹ 3.02 Cr
- Company Age 32 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 203.36 Cr
- Revenue Growth 16.37%
- Profit Growth 37.61%
- Ebitda 1.31%
- Net Worth 22.62%
- Total Assets -46.33%
About Vardhman Pharma Distributors
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110TG1992PTC168466
-
Company No.
013757
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Dec 1992
-
Date of AGM
28 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Vardhman Pharma Distributors?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Chowhan
|
Managing Director | 01-Apr-2016 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Usha Chowhan
|
Director | 17-May-2004 | Current |
|
Premkumar Karra
|
Nominee Director | 26-Nov-2009 | Current |
|
Arvind Venkat
|
Nominee Director | 23-Oct-2008 | Current |
Financial Performance of Vardhman Pharma Distributors.
Vardhman Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.37% increase. The company also saw a substantial improvement in profitability, with a 37.61% increase in profit. The company's net worth Soared by an impressive increase of 22.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vardhman Pharma Distributors?
In 2023, Vardhman Pharma Distributors had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Keimed Private LimitedArvind Venkat is a mutual person
-
Focus Medisales Private LimitedMahendra Chowhan and Usha Chowhan are mutual person
-
Srinivasa Medisales Private Limited
Mahendra Chowhan is a mutual person
-
Unnati Health Services Private Limited
Mahendra Chowhan is a mutual person
-
Neelkanth Drugs Private LimitedArvind Venkat is a mutual person
-
Vardhman Medisales Private LimitedMahendra Chowhan and Usha Chowhan are mutual person
Charges (Loans)
₹0
₹203.36 Cr
Charges Breakdown by Lending Institutions
- Others : 98.01 Cr
- Hdfc Bank Limited : 95.25 Cr
- Citibank N.A : 8.50 Cr
- State Bank Of Mysore : 1.40 Cr
- State Bank Of India : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2022 | Hdfc Bank Limited | ₹45.00 Cr | Satisfied |
| 30 Aug 2021 | Others | ₹5.00 Cr | Satisfied |
| 27 May 2021 | Others | ₹0.08 M | Satisfied |
| 06 Dec 2018 | Others | ₹54.00 Cr | Satisfied |
| 06 Dec 2018 | Others | ₹35.00 Cr | Satisfied |
How Many Employees Work at Vardhman Pharma Distributors?
Vardhman Pharma Distributors has a workforce of 423 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vardhman Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vardhman Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.